Early human infection with Onchocerca volvulus is associated with an enhanced parasite-specific cellular immune response

Journal of Infectious Diseases

Volumn 183, Issue 11, 2001, Pages 1662-1668

  Cooper, Philip J ^a,c   Mancero, Tamara ^b   Espinel, Mauricio ^b   Sandoval, Carlos ^b   Lovato, Raquel ^b   Guderian, Ronald H ^b   Nutman, Thomas B ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HOSPITAL VOZANDES   (Ecuador)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 5;

ADOLESCENT; ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ECUADOR; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; MALE; MONONUCLEAR CELL; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PARASITE SERODIAGNOSIS; PARASITE TRANSMISSION; PARASITE VIRULENCE; PARASITISM; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIGENS, HELMINTH; CHILD; DNA, HELMINTH; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-5; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035370315     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/320709     Document Type: Article

References (32)

1. Gallin M, Edmonds K, Ellner JJ, et al. Cell-mediated immune responses in human infection with Onchocerca volvulus. J Immunol 1988;140:1999-2007.
2. Ward DJ, Nutman TB, Zea Flores G, Portocarrero C, Lujan A, Ottesen EA. Onchocerciasis and Immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals, J Infect Dis 1988;157:536-43.
3. Soboslay PT, Luder CGK, Hoffmann WH, et al. Ivermectin facilitated immunity in onchocerciasis: activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection. Clin Exp Immunol 1994;96:238-44.
4. Elson LH, Calvopina HM, Paredes YW, et al. Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus. J Infect Dis 1995; 171:652-8.
5. Luder CGK, Schulz-Key H, Banla M, Pritze S, Soboslay PT. Immuno-regulation in onchocerciasis: predomínance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease. Clin Exp Immunol 1996; 105:245-53.
6. Soboslay PT, Geiger SM, Weiss N, et al. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection. Immunology 1997;90:592-9.
7. Soboslay PT, Luder CGK, Riesch S. et al. Regulatory effects of Th1-type (IFN-γ, IL-12) and Th2-type (IL-10, IL-13) cytokines on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls. Immunology 1999;97:219-25.
8. Doetze A, Satoguina J, Burchard G, Rau T, Fleischer B, Hoerauf A, Antigenspecific cellular hypo responsiveness in a chronic human helminth infection is mediated by Th3/Tr1-type cytokines IL-10 and TGF-β but not by a Th1 to Th2 shift. Int Immunol 2000;12:623-30.
9. McCarthy JS, Ottesen EA, Nutman TB. Onchocerciasis in endemic and nonendemic populations: differences in clinical presentation and immunologic findings, J Infect Dis 1994;170:736-41.
10. Luty AJF, Downham MD, Whitworth JAG, Morgan D, McNicholas A, Taylor DW. Immunological studies on onchocerciasis in Sierra Leone. I. Pretreatment baseline data. Trop Med Parasitol 1990;41:371-5.
11. Zimmerman PA, Guderian RH, Aruajo E, et al. Polymerase chain reaction-based diagnosis of Onchocerca volvulus infection: improved detection of patients with onchocerciasis. J Infect Dis 1994;169:686-9.
12. Charalambous M, Shelley AJ, Arzube M. The potential for dispersal of onchocerciasis in Ecuador in relation to the distribution of the vector Simulium exiguum (Diptera:Simuliidae). Mem Inst Oswaldo Cruz 1997; 92:153-6.
13. Rodriguez-Perez MA, Danis-Lozano R, Rodriguez MH, Bradley JE. Comparison of serological and parasitological assessments of Onchocerca volvulus transmission after 7 years of mass ivermectin treatment in Mexico. Trop Med Int Health 1999;4:98-104.
14. Cooper PJ, Espinel L Paredes W, Guderian RH, Nutman TB. Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis: a possible role for interleukin-10, J Infect Dis 1998;178:1133-8.
15. Freedman DO. Nutman TB, Ottesen EA, Protective immunity in bancroftian filariasis: selective recognition of a 43-kD larval stage antigen by infectionfree individuals in an endemic area. J Clin Invest 1989;83:14-22.
16. Mahanty S, Luke HE, Kumaraswami V, Narayanan PR, Vijayshekaran V, Nutman TB. Stage-specific induction of cytokines regulated the immune response in lymphatic filariasis. Exp Parasitol 1996;84:282-90.
17. Mahanty S, Abrams JS, King CL, Limaye AP, Nutman TB. Parallel regulation of IL-4 and IL-5 in human helminth infections. J Immunol 1992; 148:3567-71.
18. Collins RC, Lehman T, Vieira JC, Guderian RH. Vector competence of Simulium exiguum for Onchocerca volvulus: implications for the epidemiology of onchocerciasis. Am J Trop Med Hyg 1995;52:213-8.
19. Guderian RH, Shelley AJ. Onchocerciasis in Ecuador: the situation in 1989. Mem Inst Oswaldo Cruz 1992;87:405-15.
20. Bradley JE, Unnasch TR. Molecular approaches to the diagnosis of onchocerciasis. Adv Parasitol 1996;37:57-106.
21. World Health Organization (WHO), Onchocerciasis and its control: report of a WHO expert committee on onchocerciasis control. Geneva: WHO (Technical Report Series), 1995: 852.
22. Nutman TB, Paredes W, Kubofcik J, Guderian RH. Polymerase chain reaction-based assessment after macrofilaricidal therapy in Onchocerca volvulus infection. J Infect Dis 1996;173:773-6.
23. Steel C, Nutman TB. Regulation of IL-5 in onchocerciasis: a critical role for IL-2. J Immunol 1993;150:5511-8.
24. Brattig N, Nietz C, Hounkpatin S, et al. Differences in cytokine responses to Onchocerca volvulus extract and recombinant Ov33 and OvL3-1 proteins in exposed subjects with various parasitologic and clinical states. J Infect Dis 1997;176:838-42.
25. Lange AM, Yutanawiboonchai W, Scott P, Abraham D. IL-4- and IL-5-dependent protective immunity to Onchocerca volvulus infective larvae in BALB/cBYJ mice, J Immunol 1994;153:205-11.
26. Taylor MJ, Cross HF. Mohammed AA, Trees AJ, Bianco AE. Susceptibility of Brugia malayi and Onchocerca lienalis microfilariae to nitric oxide and hydrogen peroxide in cell-free culture and from IFN-γ-activated macrophages, Parasitology 1996;112:315-22.
27. Hogarth PJ, Taylor MJ, Bianco AE. IL-5-dependent immunity to microfilariae is independent of IL-4 in a mouse model of onchocerciasis. J Immunol 1998;160:5436-40.
28. Soboslay PT, Dreweck CM, Taylor HR, Brotman B. Wenk P, Greene BM. Experimental onchocerciasis in chimpanzees: cell-mediated immune responses, and production and effects of IL-1 and I1-2 with Onchocerca volvulus infection. J Immunol 1991;147:346-53.
29. Steel C. Guinea A. McCarthy JS, Ottesen EA. Long-term effect of prenatal exposure to maternal microfilaraemia on immune responsiveness to filarial parasite antigens. Lancet 1994;343:890-3.
30. Elson LH, Days A, Calvopina M. et al. In utero exposure to Onchocerca volvulus: relationship to subsequent infection intensity and cellular immune responsiveness. Infect Immun 1996;64:5061-5.
31. Steel CS, Lujan-Trangay A, Gonzalez-Peralta C. Zea-Flores G, Nutman TB. Transient changes in cytokine profiles following ivermectin treatment of onchocerciasis. J Infect Dis 1994;170:962-70.
32. King CL. Medhat A. Malhotra I. et al. Cytokine control of parasite-specific anergy in human urinary schistosomiasis, IL-10 modulates lymphocyte reactivity. J Immunol 1996;156: 4715-21.